What’s Driving Growth in the Ventral Hernia Treatment Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Anticipated CAGR of the Ventral Hernia Treatment Market, and What Factors Will Drive It?
Recent years have seen robust growth in the ventral hernia treatment market size, expected to further expand from $4.87 billion in 2024 to $5.23 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.5%. Factors that contributed to the growth during the historic period include a rise in obesity prevalence, enhanced awareness of ventral hernias, an increasing aged population, higher disposable incomes, and growing demand for minimally invasive surgical procedures.
The market for ventral hernia treatment is projected to experience substantial growth over the next few years, ballooning to $6.90 billion by 2029 with a compound annual growth rate (CAGR) of 7.2%. The primary drivers of this growth during the projected period are the escalating demand for outpatient procedures, increased healthcare spending, burgeoning government initiatives, a rising need for hernia repair surgeries, and an uptick in investments in research and development. The forecasted period is expected to witness key trends such as the advent of advanced hernia repair devices, the use of bioabsorbable materials, strategic partnerships, robotic-assisted surgical equipment, and remote patient monitoring.
What Factors Are Propelling the Growth of the Ventral Hernia Treatment Market from 2025 to 2034?
The growing incidence of obesity is anticipated to drive the expansion of the ventral hernia treatment market. Obesity, defined as a critical health condition caused by excessive body fat, can significantly affect an individual’s wellbeing. Poor dietary habits, a sedentary lifestyle, genetic predispositions, insufficient physical exercise, environmental factors, and emotional stress all contribute to a rising obesity rate. Ventral hernia treatment plays a crucial role for obese individuals. It deals with the issues brought about by excessive weight, including reducing the undue pressure on the abdominal wall, minimizing the chances of hernia recurrence, and increasing overall abdominal strength. These factors are important for enhancing mobility and encouraging healthier lifestyle habits among individuals grappling with obesity. For instance, the intergovernmental organization based in Switzerland, the World Health Organization (WHO), reported in March 2024 that about one in eight people globally were dealing with obesity. This included 2.5 billion adults (over 18 years) who were overweight, with 890 million among them experiencing obesity. Among adults, 43% were overweight, and 16% were categorised as obese. Furthermore, the number of overweight children under the age of 5 stood at 37 million. Thus, the escalating prevalence of obesity stimulates the ventral hernia treatment market.
Request Your Free Ventral Hernia Treatment Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21315&type=smp
Who Are the Top Companies Contributing to the Growth of the Ventral Hernia Treatment Market?
Major companies operating in the ventral hernia treatment market are Johnson And Johnson Services Inc., AbbVie, Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company (BD), Baxter International Inc., Braun Melsungen AG, Zimmer Biomet, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc., KARL STORZ, Cooper University Health Care, Mölnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Tela Bio, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd.
How Are Technological Trends Affecting the Growth and Development of the Ventral Hernia Treatment Market?
Technological developments such as the laparoscopic and open hernia mesh fixation devices are being focused on by key players in the ventral hernia treatment market. These devices, which serve to secure the mesh during hernia repair surgeries, are designed to enhance surgical outcomes, reduce complications, and aid patient recovery through minimally invasive (laparoscopic) or traditional open surgical methods. For instance, TELA Bio Inc., a medical tech firm based in the US, in March 2024, rolled out their LIQUIFIX FIX8 laparoscopic and LIQUIFIX precision open hernia mesh fixation devices within the US. Designed for minimal invasive surgeries, LIQUIFIX FIX8, and for open femoral and inguinal hernia repairs, LIQUIFIX precision, these FDA-approved devices make use of liquid anchors to secure the mesh without tissue penetration to lessen trauma and complications. LIQUIFIX, catering to over 1.2 million hernia procedures annually in the U.S., ensures precision and safety in sensitive zones, and minimizes the risk of vascular or nerve injury.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/ventral-hernia-treatment-global-market-report
Which Segments of the Ventral Hernia Treatment Market Hold the Most Potential for Future Development?
The ventral hernia treatment market covered in this report is segmented –
1) By Type: Epigastric (Stomach Area) Hernia, Umbilical (Belly Button) Hernia, Incisional Hernia
2) By Diagnosis: Ultrasound, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)
3) By Surgery: Open Hernia Surgery, Laparoscopic Surgery, Robotic Hernia Surgery
4) By End Users: Hospitals, Ambulatory Surgical Centres, Clinics
Subsegments:
1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia, Large Epigastric Hernia
2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia, Acquired Umbilical Hernia
3) By Incisional Hernia: Primary Incisional Hernia, Recurrent Incisional Hernia
What Are the Key Regions Powering Growth in the Ventral Hernia Treatment Market?
North America was the largest region in the ventral hernia treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the ventral hernia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Defines the Scope of the Ventral Hernia Treatment Market?
Ventral hernia treatment refers to the medical procedures and interventions used to repair hernias that occur in the abdominal wall. It typically involves the use of robotic-assisted surgery, tension-free mesh repair, and laparoscopic intraperitoneal. The treatment aims to reposition displaced tissues, strengthen the abdominal wall, and prevent recurrence. These treatments are used to relieve pain, restore normal function, and reduce the risk of complications such as bowel obstruction or strangulation.
Browse Through More Similar Reports By The Business Research Company:
Pneumococcal Vaccine Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pneumococcal-vaccine-global-market-report
Travel Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report
Vaccine Contract Manufacturing Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: